Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775808 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18775805 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL10067084 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18775811 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18775804 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18775803 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18776003 | 0.98 | ALDH1A1 (0.41) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL10067085 | 0.96 | ALDH1A1 (0.39) | ALDH1A1ADRB2ADRB1ADRB3CES2 | |
| SCHEMBL18775801 | 0.93 | SMN1; SMN2 (0.37) | ALDH1A1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL18775925 | 0.89 | KMT2A (0.33) | ALDH1A1MAPTL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394570-B2 | Sulfonium salt, acid generator, resist composition, photomask blank, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20100143830-A1 | SULFONIUM SALT, ACID GENERATOR, RESIST COMPOSITION, PHOTOMASK BLANK, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143830-A1 | SULFONIUM SALT, ACID GENERATOR, RESIST COMPOSITION, PHOTOMASK BLANK, AND PATTERNING PROCESS | TYK2, VRK2, ARSA | ALDH1A1 3818/4885ADRB2 2422/4885ADRB1 2478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.